Estrogenic compounds as anti-mitotic agents
US6930128B2 · kind B2 · utility
19Cited by
24References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2003 |
| Grant date | Aug 16, 2005 |
| Priority date | — |
| Expiry date | Feb 7, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J63/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The application discloses methods of treating mammalian diseases characterized by abnormal cell mitosis by administering estradiol derivatives including those comprising colchicine or combretastatin A-4 structural motifs of the general formulae found below in a dosage sufficient to inhibit cell mitosis. The application discloses novel compounds used in the methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.